Patent AT-E400652-T1: [Translated] TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS
Description
The invention concerns new tumor necrosis factor receptor associated factors, designated TRAFs. The new factors are capable of specific association with the intracellular domain of the type 2 TNF receptor (TNF-R2) and CD40, and are involved in the mediation of TNF and CD40 ligand biological activities.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400652-T1: [Translated] TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400652-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem